These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 29090602)
1. Synthesis and antitumor activities of sinomenine derivatives on rings A and C. Wei CJ; Xu F; Shi MJ; Hu JW; Wang JJ; Zhen B; Wang X; Ji TF; Wang JH; Du GH J Asian Nat Prod Res; 2018 Mar; 20(3):277-291. PubMed ID: 29090602 [TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, Biological Evaluation and Silico Prediction of Novel Sinomenine Derivatives. Li S; Gao M; Nian X; Zhang L; Li J; Cui D; Zhang C; Zhao C Molecules; 2021 Jun; 26(11):. PubMed ID: 34200341 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and molecular docking studies of sinomenine derivatives. Chai X; Guan Z; Yu S; Zhao Q; Hu H; Zou Y; Tao X; Wu Q Bioorg Med Chem Lett; 2012 Sep; 22(18):5849-52. PubMed ID: 22892114 [TBL] [Abstract][Full Text] [Related]
4. Sinomenine Induces G1-Phase Cell Cycle Arrest and Apoptosis in Malignant Glioma Cells Via Downregulation of Sirtuin 1 and Induction of p53 Acetylation. He X; Maimaiti M; Jiao Y; Meng X; Li H Technol Cancer Res Treat; 2018 Jan; 17():1533034618770305. PubMed ID: 29756546 [TBL] [Abstract][Full Text] [Related]
5. Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity. Bao N; Ou J; Xu M; Guan F; Shi W; Sun J; Chen L Eur J Med Chem; 2017 Sep; 137():88-95. PubMed ID: 28558333 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological activities of sorafenib derivatives as antitumor agents. Yao J; He Z; Chen J; Sun W; Fang H; Xu W Bioorg Med Chem Lett; 2012 Nov; 22(21):6549-53. PubMed ID: 23021967 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological antitumor evaluation of tetrahydroisoquinoline derivatives. Pang C; Zhao J; Zhang S; Chen J; Zeng X; Li H Bioorg Med Chem Lett; 2024 Sep; 109():129824. PubMed ID: 38823729 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-proliferative activity of fluoro-substituted chalcones. Burmaoglu S; Algul O; Anıl DA; Gobek A; Duran GG; Ersan RH; Duran N Bioorg Med Chem Lett; 2016 Jul; 26(13):3172-3176. PubMed ID: 27217001 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives. Zheng M; Xu C; Ma J; Sun Y; Du F; Liu H; Lin L; Li C; Ding J; Chen K; Jiang H Bioorg Med Chem; 2007 Feb; 15(4):1815-27. PubMed ID: 17157510 [TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of new tetrandrine derivatives and their antitumor activities. Wei X; Qu TL; Yang YF; Xu JF; Li XW; Zhao ZB; Guo YW J Asian Nat Prod Res; 2016 Oct; 18(10):966-75. PubMed ID: 27244089 [TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of novel 2'-hydroxy group substituted 2-pyridone derivatives as anticancer agents. Lv Z; Zhang Y; Zhang M; Chen H; Sun Z; Geng D; Niu C; Li K Eur J Med Chem; 2013 Sep; 67():447-53. PubMed ID: 23920246 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of tetrandrine derivatives. Wu CZ; Lai L; Hu X; Lei RR; Yang YF J Asian Nat Prod Res; 2013 Sep; 15(9):993-1002. PubMed ID: 23944846 [TBL] [Abstract][Full Text] [Related]
13. D-ring modified novel isosteviol derivatives: design, synthesis and cytotoxic activity evaluation. Zhang T; Lu LH; Liu H; Wang JW; Wang RX; Zhang YX; Tao JC Bioorg Med Chem Lett; 2012 Sep; 22(18):5827-32. PubMed ID: 22901386 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of imidazoline derivatives as p53-MDM2 binding inhibitors. Hu C; Li X; Wang W; Zhang L; Tao L; Dong X; Sheng R; Yang B; Hu Y Bioorg Med Chem; 2011 Sep; 19(18):5454-61. PubMed ID: 21855354 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and Anticancer Study of Novel 4H-Chromen Derivatives. Lu X; Dong G; Zheng Y; Zhang C; Qiu Y; Lua T; Zhou X Anticancer Agents Med Chem; 2017; 17(8):1070-1083. PubMed ID: 27141877 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells. Xia Y; Dong ZW; Zhao BX; Ge X; Meng N; Shin DS; Miao JY Bioorg Med Chem; 2007 Nov; 15(22):6893-9. PubMed ID: 17804244 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and cancer cell growth inhibitory activity of icaritin derivatives. Wang C; Wu P; Shi JF; Jiang ZH; Wei XY Eur J Med Chem; 2015 Jul; 100():139-50. PubMed ID: 26079090 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and in vitro antiproliferative activity of novel Dasatinib derivatives. Cai J; Zhang S; Zheng M; Wu X; Chen J; Ji M Bioorg Med Chem Lett; 2012 Jan; 22(2):806-10. PubMed ID: 22217877 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities. Yoon YK; Ali MA; Wei AC; Choon TS; Osman H; Parang K; Shirazi AN Bioorg Med Chem; 2014 Jan; 22(2):703-10. PubMed ID: 24387981 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and in vitro antitumor evaluation of novel diaryl ureas derivatives. Sun M; Wu X; Chen J; Cai J; Cao M; Ji M Eur J Med Chem; 2010 Jun; 45(6):2299-306. PubMed ID: 20181414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]